Header cover image
  • Investing Ideas
  • /
  • Pakistani Pharmaceuticals & Biotech Undervalued based on future growth

Pakistani Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Searle

Market Cap: PK₨49.7b

Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.

SEARL

PK₨97.17

7D

2.3%

1Y

67.0%